Potassium iodide tabs
Ended Awarded Last action
- Contract number
- SPE2DR26FMJS4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,650
Award facts
- Contract value 100% obligated
- $34,650.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,650 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of potassium iodide tablets. The contract, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V represents a critical component of the Department of Defense's pharmaceutical supply chain strategy, positioning DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products and medical consumables to military healthcare facilities worldwide. The vendor's performance across numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for federal military medical operations. As a participant in this broader $30.3 billion acquisition program, DMS Pharmaceutical Group supports the recurring medical supply needs of Defense Department healthcare operations through firm fixed-price delivery orders for branded and generic prescription medications, biologics, and related medical products.
Quick answers
Who was awarded contract SPE2DR26FMJS4?
SPE2DR26FMJS4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FMJS4 worth?
The government has obligated $34,650 on SPE2DR26FMJS4.
Is contract SPE2DR26FMJS4 an order under another contract?
Yes. SPE2DR26FMJS4 is a delivery order under SPE2DR25D9901, an indefinite delivery contract.
Was contract SPE2DR26FMJS4 competed?
The extent of competition for SPE2DR26FMJS4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award